Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06548061 · ClinicalTrials.gov registry record · NA
D20054;LITT for Spine Tumors
A NA study of Spinal Metastases, sponsored by Dartmouth-Hitchcock Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06548061 is a NA study of Spinal Metastases that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 25 participants, below the 113-participant average among 5 other Spinal Metastases trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06548061, a NA study of Spinal Metastases, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this clinical study is to evaluate the efficacy and safety of spinal laser interstitial therapy in the treatment of metastatic spinal tumors. The investigators hypothesize that rates of local tumor control are comparable between conventional open surgical techniques and spinal laser interstitial therapy.
Conditions Studied
Interventions
- DEVICE ClearPoint Prism
Study Locations (1)
New Hampshire
- Dartmouth Health - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2024-05-16 |
| Est. Completion | 2029-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06548061
The ClinicalTrials.gov registry entry for NCT06548061 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 113-participant average among 5 other Spinal Metastases trials with a reported enrollment target (78% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Spinal Metastases appearing as the primary indexed condition, and to 1 intervention - of which ClearPoint Prism is the first listed.
NCT06548061 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.
Frequently Asked Questions
What is clinical trial NCT06548061 about?
NCT06548061 is a clinical study titled "D20054;LITT for Spine Tumors". The objective of this clinical study is to evaluate the efficacy and safety of spinal laser interstitial therapy in the treatment of metastatic spinal tumors. The investigators hypothesize that rates of local tumor control are comparable between conventional open surgical techniques and spinal laser...
What is the current status of trial NCT06548061?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-05-16. Estimated completion is 2029-06-01.
What conditions does trial NCT06548061 study?
This clinical trial studies the following conditions: Spinal Metastases.
What interventions are being tested in trial NCT06548061?
The interventions under investigation include: ClearPoint Prism (DEVICE).
Who is sponsoring clinical trial NCT06548061?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06548061 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stereotactic Body Radiotherapy for Spine Tumors
COMPLETED · NA
-
Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases
RECRUITING · Phase 3
-
A Prospective Study of Performing MRI Simulation in Treatment Position in Spinal Stereotactic Body Radiation Therapy
ACTIVE NOT RECRUITING
-
Validation of Novel Predictive Score for Patients With Spinal Metastases
COMPLETED
-
Intra-arterial Chemotherapy for Spinal Metastases
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.